Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

AIMS: Current evidence about the effect of angiotensin receptor blocker (ARB) on the outcome of heart failure with mid‐range ejection fraction (HFmrEF) is lacking. We aim to assess the association between use of ARB and 1 year all‐cause mortality after hospitalization for HFmrEF. METHODS AND RESULTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin, Zhang, Lihua, Hu, Shuang, Bai, Xueke, Li, Xi, Li, Jing, Zheng, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006710/
https://www.ncbi.nlm.nih.gov/pubmed/33619915
http://dx.doi.org/10.1002/ehf2.13229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006710/
https://www.ncbi.nlm.nih.gov/pubmed/33619915
http://dx.doi.org/10.1002/ehf2.13229

Ejemplares similares